What Xenon Pharmaceuticals Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 2 | 2 |
| Sells | 3 | 26 |
| Total trades | 7 | 51 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 57,644 | 444,659 |
| Disposed | 17,068 | 384,421 |
| Net activity | +40,576 | +60,238 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kelly Thomas Patrick | Chief Financial Officer | Oct 15 | Exercise / conversion · M | +7,500 | — | — | 22,500 |
| Mortimer Ian | PRESIDENT & CEO | Sep 30 | Open-market buy · P | +30,000 | $37.38 | +$1.12M | 49,923 |
| Kelly Thomas Patrick | Chief Financial Officer | Sep 30 | Open-market buy · P | +15,000 | $37.32 | +$560K | 15,000 |
| Graham Dawn | Director | Sep 01 | Exercise / conversion · M | +5,144 | $8.15 | +$41.9K | 31,373 |
| Kenney Christopher John | Chief Medical Officer | Aug 28 | Sale for tax withholding · S | −700 | $60.98 | −$42.7K | 2 |
| Kenney Christopher John | Chief Medical Officer | Aug 28 | Disclosed 10b5-1 sale · S | −6,368 | $60.17 | −$383K | 702 |
| Gannon Steven | Director | Aug 11 | Open-market sale · S | −10,000 | $64.06 | −$641K | 1,870 |
| Cannon Gillian | Director | Jun 05 | Disclosed 10b5-1 sale · S | −1,190 | $53.14 | −$63.2K | 1,455 |
| Patou Gary | Director | Jun 05 | Disclosed 10b5-1 sale · S | −1,322 | $53.14 | −$70.3K | 24,896 |
| Garofalo Elizabeth A. | Director | Jun 01 | Exercise / conversion · M | +2,645 | — | — | 2,645 |
| Cannon Gillian | Director | Jun 01 | Exercise / conversion · M | +2,645 | — | — | 2,645 |
| Machado Clarence Patrick | Director | Jun 01 | Exercise / conversion · M | +2,645 | — | — | 2,645 |
| Gover Justin D. | Director | Jun 01 | Exercise / conversion · M | +2,645 | — | — | 2,645 |
| Graham Dawn | Director | Jun 01 | Withheld — tax / exercise cost · F | −1,416 | $53.41 | −$75.6K | 26,229 |
| Graham Dawn | Director | Jun 01 | Exercise / conversion · M | +2,645 | — | — | 27,645 |
| Gannon Steven | Director | Jun 01 | Withheld — tax / exercise cost · F | −1,416 | $53.41 | −$75.6K | 11,870 |
| Gannon Steven | Director | Jun 01 | Exercise / conversion · M | +2,645 | — | — | 13,286 |
| Patou Gary | Director | Jun 01 | Exercise / conversion · M | +2,645 | — | — | 26,218 |
| Gannon Steven | Director | May 12 | Exercise / conversion · M | +3,500 | $7.38 | +$25.8K | 10,641 |
| Kenney Christopher John | Chief Medical Officer | Mar 13 | Disclosed 10b5-1 sale · S | −1,410 | $55.23 | −$77.9K | 7,069 |
Loading...
